Breast cancer diagnosis by scintimammography: A meta-analysis and review of the literature

Breast Cancer Research and Treatment

Volumn 80, Issue 1, 2003, Pages 115-126

  Liberman, Moishe ^a   Sampalis, Fotini ^b   Mulder, David S ^a   Sampalis, John S ^a,b  

^a MONTREAL GENERAL HOSPITAL   (Canada)

^b HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

Author keywords

Breast cancer; Diagnosis; Mammogram; Meta analysis; Scintimammography; Screening

Indexed keywords

BREAST CANCER; CLINICAL EXAMINATION; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; HUMAN; MEDLINE; META ANALYSIS; MULTICENTER STUDY; PRIORITY JOURNAL; RELIABILITY; REVIEW;

BREAST NEOPLASMS; FEMALE; HUMANS; MAMMOGRAPHY; RADIOPHARMACEUTICALS; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 0037823138     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1024417331304     Document Type: Review

References (81)

1. American Cancer Society: Cancer Facts and Figures 1999. American Cancer Society, Atlanta, GA, 1999
2. Sondik EJ: Breast cancer trends. Incidence, mortality and survival. Cancer 74: 995-999, 1994
3. Fever EJ, Wu LM, Boring CC: The lifetime risk of developing breast cancer. JNCL 85: 892-897, 1993
4. Cox PH, Belfer AJ, Van der Pompe WB: Thallium-201 chloride uptake in tumors, a possible complication in heart scintigraphy. Brit J Radiol 49: 767-768, 1976
5. Campeau RJ, Kronemer KA, Sutherland CM: Concordant uptake of Tc-99m sestamibi and T1-201 in unsuspected breast tumor. Clin Nucl Med 17: 936-937, 1992
6. Williams MB, Schnall MD: Future imaging in the diagnosis of breast diseases. Radiology 206: 297-300, 1998
7. Kopans DB: The positive predictive value of mammography. Am J Roentgenol 158: 521-526, 1992
8. Pillsbury SG, Haugen JA, Roux S: Reliability of multimodal evaluation of abnormal screening mammogram results. Am J Obstet Gynecol 174: 1683-1687, 1996
9. Mann BD, Giuliano AE, Bassett LW, Barber MS, Hallauer W, Morton DL: Delayed diagnosis of breast cancer as a result of normal mammograms. Arch Surg-Chicago 118: 23-24, 1983
10. Khalkhali I, Mena I, Diggles L: Review of imaging techniques for the diagnosis of breast cancer: a new role of prone scintimammography using technetium-99m sestamibi. Eur J Nucl Med 21: 357-362, 1994
11. Dunwald LK, Hartnett SD, Mankoff DA: Utility and reproducibility of semiquantitative analysis of sestamibi breast images. J Nucl Med Technol 25: 106-109, 1997
12. Elmore JG, Barton MB, Moceri VM, Polk S, Arena PJ, Fletcher SW: Ten-year risk of false positive screening mammograms and clinical breast examinations. NEJM 383: 1089-1096, 1998
13. 99mTc-antigranulocyte bone marrow scintigraphy of breast and prostate skeletal metastases. Anticancer Res 17: 1615-1618, 1997
14. Nishiyam Y, Yamamoto Y, Kawasaki Y, Satoh K, Takashima H, Ohkawa M, Tanabe M: Accumulation of Tc-99m MIBI in breast lymphomacomparison with Ga-67 citrate. Ann Nucl Med 10: 429-432, 1996
15. Chandramouly BS, Tiu S, Castronuovo JJ: Uptake of gallium in the breasts. Semin Nucl Med 14: 149-151, 1984
16. 99mTc-Q12 into human breast cancer cell lines. Eur J Nucl Med 23: 1361-1366, 1996
17. Hillner BE: Decision analysis: MIBI imaging of nonpalpable breast abnormalities. J Nucl Med 38: 1772-1778, 1997
18. Akcay MN, Akin Y, Karabag B, Ozcan O, Oren D: Tc-99m tetrofosmin in breast carcinoma and axillary lymph node metastases: a comparative study with Tc-99m MIBI. Clin Nucl Med 22: 832-834, 1997
19. Alonso JC, Soriano A, Zarca MA, Guerra P, Alcazar R, Molino C: Breast cancer detection with sestamibi-Tc-99m and TI-201 radionucleotides in patients with non-conclusive mammography. Anticancer Res 17: 1661-1665, 1997
20. Arslan N, Ozturk E, Ilgan S, Urhan M, Karacalioglu O, Pekcan M, Tufan T, Bayhan H: 99Tcm-MIBI scintimammography in the evaluation of breast lesions and axillary involvement: a comparison with mammography and histopathological diagnosis. Nucl Med Commun 20: 317-325, 1999
21. Bajc M, Ingvar C, Palmer J: Dynamic indium-111-pentetreotide scintigraphy in breast cancer. J Nucl Med 37: 622-626, 1996
22. Batista JF, Solano ME, Oliva JP, Rodriguez JL, Gomez J, Stusser RJ, Sanchez E: Usefulness of 99Tcm-tetrofosmin scintimammography in palpable breast tumours. Nucl Med Commun 18: 338-340, 1997
23. Becherer A, Helbich T, Staudenherz A, Jakesz R, Kubista E, Lehner R, Rudas M, Teleky B, Kltter K, Leitha T: The diagnostic value of planar and SPET scintimammography in different age groups. Nucl Med Commun 18: 710-718, 1997
24. Berghammer P, Obwegeser R, Mullauer-Ertl S, Karanikas G, Wiltschke C, Kubista E, Sinzinger H, Zielinski C: 99m-Tc-tetrofosmin scintigraphy and breast cancer. Gynecol Oncol 73: 87-90, 1999
25. 99mTc-tetrofosmin scintimammography related to surgery. Eur J Surg Oncol 25: 152-156, 1999
26. m-MIBI: a comparative study with mammography and ultrasonography. Nucl Med Commun 15: 604-612, 1994
27. Buscombe JR, Cwilka JB, Thakrar DS, Parbhoo SP, Hilson AJ: Prone SPET scintimammography. Nucl Med Commun 20: 237-245, 1999
28. Cancroft E, Goldfarb CR: Breast Scintigraphy as an imaging modality in the diagnosis of breast masses. Semin Nucl Med 11: 289-300, 1981
29. Carril JM, Gomez-Barquin R, Quirce R, Tabuenca O, Uriarte I, Montero A: Contribution of 99mTc-MIBI scintimammography to the diagnosis of non-palpable breast lesions in relation to mammographic probability of malignancy. Anticancer Res 17: 1677-1682, 1997
30. Chen SL, Yin YQ, Chen JX, Sun XG, Xiu Y, Liu WG, Liu M, Zhu WM, Zhang YB: The usefulness of technetium-99m-MIBI scintimammography in diagnosis of breast cancer: using surgical histopathologic diagnosis as the gold standard. Anticancer Res 17: 1695-1698, 1997
31. Chiti A, Agresti R, Maffioli LS, Tomasic G, Savelli G, Crippa F, Pilotti S, Greco M, Bombardieri E: Breast cancer staging using technetium-99m sestamibi and indium-111 pentreotride single photon emission tomography. Eur J Nucl Med 24: 192-196, 1997
32. Cimitan M, Volpe R, Candiani E, Gusso G, Ruffo R, Borsatti E, Massarut S, Rossi C, Morassut S, Carbone A: The use of thallium-201 in the preoperative detection of breast cancer: an adjunct to mammography and ultrasonography. Eur J Nucl Med 22: 1110-1117, 1995
33. Clifford EJ, Lugo-Zamudio C: Scintimammography in the diagnosis of breast cancer. Am J Surg 172: 483-486, 1996
34. m-diethylene triamine penta-acetic acid - a prospective blind evaluation. Brit J Surg 68: 147-149, 1981
35. Cutrone JA, Khalkhali I, Yospur LS, Diggles L, Weinberg I, Pong EM, Tolmos J, Vargas MP, Vargas HI: Tc99m sestamibi scintimammography for the evaluation of breast masses in patients with radiographically dense breasts. Breast J 5: 383-388, 1999
36. m-MIBI in the assessment of patients with suspected recurrent breast cancer. Nucl Med Commun 19: 649-655, 1998
37. 99mTc-sestamibi. Acta Radiol 40: 394-399, 1999
38. De Vincentis G, Scoparino F, Pani R, Pelligrini R, Soluri A, Ierardi M, Ballesio L, Weinberg IN, Pergola A: 99mTcMIBI scintimammogmphy with a high resolution single tube gamma camera. Anticancer Res 17: 1627-1630, 1997
39. 99mTc-diethylene triamene penta-acetic acid for the detection of malignant disease. Brit J Surg 73: 613-614, 1986
40. 99mTc-sestamibi scintimammography by SPEM camera in the management of breast cancer in the elderly. Breast Cancer Res Tr 48: 159-163, 1998
41. Fenlon HM, Phelan N, Tierney S, Gorey T, Ennis JT: Tc-99m tetrofosmin scintigraphy as an adjunct to plain film mammography in palpable breast lesions. Clin Radiol 53: 17-24, 1998
42. Flanagan DA, Gladding SB, Lovell FR: Can scintimammography reduce "unneccessary" biopsies? Am Surgeon 64: 670-673, 1998
43. Helbich TH, Becherer A, Trattnig S, Leitha T, Kelkar P, Seifert M, Gnant M, Staudehherz A, Rudas M, Wolf G, Mostbeck GH: Differentiation of benign and malignant breast lesions: MR imaging versus Tc-99m sestamibi scintimammography. Radiology 202: 421-429, 1997
44. Howarth D, Sillar R, Lan L, Clark D, Miles T: Scintimammography: an adjunct test for the detection of breast cancer. MJA 170: 588-591, 1999
45. Kao CH, Wang SJ, Liu TJ: The use of technetium-99m methoxyisobutylisonitrile breast scintigraphy to evaluate palpable breast masses. Eur J Nucl Med 21: 432-436, 1994
46. Khalkhali I, Cutrone JA, Diggles E, Klein SR: Scintimammography with Tc-99m sestamibi. Acta Med Aust 24: 46-49, 1997
47. Khayat G, Achram M, Rizk G: The role of breast scintigraphy in detecting breast masses. Brit J Radiol 58: 721-724, 1985
48. Lam WWM, Yang WT, Chan YL, Stewart IE, King W, Metreweli C: Role of MIBI breast scintigraphy in evaluation of palpable breast lesions. Brit J Radiol 69: 1152-1158, 1996
49. Lee VW, Sax EJ, McAneny DB, Pollack S, Blanchard RA, Beazley RM, Kavanah MT, Ward RJ: A complementary role for thallium-201 scintigraphy with mammography in the diagnosis of breast cancer. J Nucl Med 34: 2095-2100, 1993
50. Lee JK, Kao CH, Sun SS: Technetium-99m methylene diphosphonate scintimammography for evaluation of palpable breast masses. Oncol Rep 6: 659-663, 1999
51. Lind P, Umschaden W, Forsthuber E, Oman J, Kerschbaumer K, Gallowitsch HJ, Mikosch P, Kresnik E, Molnar M, Gomez I: Scintimammography using Tc-99m tetrofosmin. Acta Med Aust 24: 50-54, 1997
52. Maffioli L, Agresti R, Chiti A, Crippa F, Gasparini M, Greco M, Bombardieri E: Prone scinthnammography in patients with non-palpable breast lesions. Anticancer Res 16: 1269-1274, 1996
53. Mangkharak J, Patanachak C, Podhisuwan K, Pleehachinda R: The evaluation of combined scintimammography and tumor markers in breast cancer patients. Anticancer Res 17: 1611-1614, 1997
54. Mangkharak J: Scintimammography (SMM) in breast cancer patients. J Med Assoc Thai 82: 242-249, 1999
55. Mansi L, Rambaldi PF, Procaccini E, Gregorio FD, Laprovitera A, Pecori B, Vecchio WD: Scintimammography with technetium-99m tetrofosmin in the diagnosis of breast cancer and lymph node metastases. Eur J Nucl Med 23: 932-939, 1996
56. 99mTc tetrofosmin imaging in breast cancer. Eur J Gynaecol Oncol 19: 163-166, 1998
57. Maublant J, de Latour M, Mestas D, Clemenson A, Charrier S, Feillel V, Le Bouedec G, Kaufmann P, Dauplat J, Veyre A: Technetium-99m-sestamibi uptake in breast tumor and associated lymph nodes. J Nucl Med 37: 922-925, 1996
58. Maurer AH, Caroline DF, Jadali FJ, Manzone TA, Maier WP, Au FC, Schnall SF: Limitations of craniocaudal thallium-201 and technetium-99m-sestamibi mammoscintigraphy. J Nucl Med 36: 1696-1700, 1995
59. McQuarrie SA, MacLean GD, Boniface GR, Goldberg K, McEwan AJB: Radioimmunoscintigmphy in patients with breast adenocarcinoma using technetium-99m labelled monoclonal antibody 170H.82: report of a phase II study. Eur J Nucl Med 24: 381-389, 1997
60. Mekhmandarov S, Sandbank J, Cohen M, Lelcuk S, Lubin E: Technetium-99m-MIBI scintimammography in palpable and non-palpable breast lesions. J Nucl Med 39: 86-91, 1998
61. 99mTc-sestamibi scintimammography and trans-scan in diagnosing breast cancer. J Nucl Med 40: 376-380, 1999
62. Mondal A, Sharma R, Chakravarty KL, Mishra P, Sahay K, Bhatnagar A, Gupta A, Sawroop K: Delayed Tc-99m citrate scintigraphy in the evaluation of palpable breast masses. Clin Nucl Med 24: 309-313, 1999
63. Moretti JL, Azaloux H, Boisseron D, Kouyoumdjian JC, Vilcoq J: Primary breast cancer imaging with technitium-99m sestamibi and its relation with P-glycoprotein overexpression. Eur J Nucl Med 23: 980-986, 1996
64. Palmedo H, Schomburg A, Grunwald F, Mallmann P, Krebs D, Biersack HJ: Technetium-99m-MIBI scintimammography for suspicious breast lesions. J Nucl Med 37: 626-630, 1996
65. Palmedo H, Biersack HJ, Lastoria S, Maublant J, Prats E, Stegner HE, Bourgeois P, Hustinx R, Hilson AJ, Bischof-Delaloye A: Scintimammography with technetium-99m methoxyisobutylisonitrile: results of a prospective European multicentre trial. Eur J Nucl Med 25: 375-385, 1998
66. Pauwels EKJ, Den Outer AJ, Hermans J, Obermann WR, Zwaveling A: Scintigraphy of the female breast with Tc-99m-DTPA: a prospective blind evaluation. Am J Physiol Imaging 1: 91-95, 1986
67. 99mTc-MDP in the detection of primary breast cancer. Q J Nucl Med 41: 225-230, 1997
68. 99mTc-MIBI scintimammography in suspected breast cancer. J Nucl Med 40: 296-301, 1999
69. 201T1 scintigraphy. Brit J Radiol 68: 1052-1057, 1995
70. Schillaci O, Scoparino F, Danieli R, Tavolaro R, Picardi V, Cannas P, Colella AC: 99Tcm-sestamibi scintimammography in patients with suspicious breast lesions: comparison of SPET and planar images in the detection of primary tumours and axillary lymph node involvement. Nucl Med Commun 18: 839-845, 1997
71. Scoparino F, Schillaci O, Ussof W, Nordling K, Capoferro R, De Vincentis G, Danieli R, Ierardi M, Picardi V, Tavolaro R, Colella AC: A three center study on the diagnostic accuracy of 99mTc-MIBI scintimammography. Anticancer Res 17: 1631-1634, 1997
72. 201T1 scintigraphy in the staging of lung cancer, breast cancer and lymphoma. Nucl Med Commun 11: 263-269, 1990
73. Sillar R, Howarth D, Clark D: The initial Australian experience of technetium-99m sestamibi scintimammography: a complementary test in the management of breast cancer. Aust NZ J Surg 67: 433-437, 1997
74. Sommer H, Tiling R, Pechmann M, Kindermann G, Kress K, Moser R, Tatsch K, Hahn K, Pfluger T, Assemi C: Evaluation of mammographic lesions with Tc-99m sestamibi scintimammography and contrast enhanced MRI. Zbl Gynakol 119: 6-11, 1997
75. Taillefer R, Robidoux A, Lampert R, Turpin S, Laperriere J: Technetium-99m-sestamibi prone scintimammography to detect primary breast cancer and axillary lymph node involvement. J Nucl Med 36: 1758-1765, 1995
76. Tiling R, Khalkhali I, Sommer H, Linke R, Moser R, Willemsen F, Pfluger T, Tatsch K, Hahn K: Limited value of scintimammography and contrast-enhanced MRI in the evaluation of microcalcification detected by mammography. Nucl Med Commun 19: 55-62, 1998
77. Tolmos J, Cutrone JA, Wang B, Vargas HI, Stuntz M, Mishkin FS, Diggles LE, Venegas RJ, Klein SR, Khalkhali I: Scintimammography analysis of nonpalpable breast lesions previously identified by conventional mammography. J Natl Cancer 190: 846-849, 1998
78. Uriarte I, Carril JM, Quirce R, Gutierrez-Mendiguchia C, Blanco I, Banzo I, Vega A, Hernandez A: Optimization of X-ray mammography and technetium-99m methoxyisobutylisonitrile scintimammography in the diagnosis of non-palpable breast lesions. Eur J Nucl Med 25: 491-496, 1998
79. Villanueva-Meyer J, Leonard MH, Briscoe E, Cesani F, Ali SA, Rhoden S, Hove M, Cowan D: Mammoscintigraphy with technetium-99m-sestamibi in suspected breast cancer. J Nucl Med 37: 926-930, 1996
80. Waxman AD, Ramanna L, Memsic LD, Foster CE, Silberman AW, Gleischman SH, Brenner RJ, Brachman MB, Kuhar CJ, Yadegar J: Thallium scintigraphy in the evaluation of mass abnormalities of the breast. J Nucl Med 34: 18-23, 1993
81. Yuen-Green M, Wasnich R, Caindec-Ranchez S, Davis J: New method for breast cancer detection using Tc-99m sestamibi scintimammography. Hawaii Med J 55: 26-28, 1996